These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7126890)

  • 1. [Metastatic breast carcinoma: sequential hormonotherapy with tamoxifen and medroxy-progesterone acetate. preliminary results].
    Bosset JF; Pereal M; Hurteloup P; Altwegg T; Del Piano F; Colette C; Schraub S
    Bull Cancer; 1982; 69(2):170-1. PubMed ID: 7126890
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sequential therapy with antiestrogens and progestational drugs in carcinoma of the breast in an advanced stage].
    Palmeri R; Papalia E; Lazzara S; Belnome NA; Gorgone S; Calbo E; Melita P
    Chir Ital; 1987 Apr; 39(2):185-92. PubMed ID: 2958166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
    Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endocrine treatment of metastasizing breast cancer in menopausal women. A randomized comparison between tamoxifen (Nolvadex) versus tamoxifen and medroxyprogesterone acetate (Clinovir)].
    Mouridsen HT; Ellemann K; Mattsson W; Palshof T; Daehnfeldt J; Rose C
    Ugeskr Laeger; 1979 Jul; 141(31):2113-6. PubMed ID: 483409
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
    Pannuti F; Martoni A; Fruet F; Strocchi E; Di Marco AR
    Eur J Cancer (1965); 1980; Suppl 1():93-8. PubMed ID: 6459237
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
    Trodella L; Ausilli-Cefaro GP; Turriziani A; Saccheri S; Venturo I; Minotti G
    Am J Clin Oncol; 1982 Oct; 5(5):495-9. PubMed ID: 6217741
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metastatic breast cancer: controlled treatment trial of chemotherapy combined with hormone therapy using medroxyprogesterone alone or combined with tamoxifen].
    Jouve M; Palangie T; Bretaudeau B; Garcia-Giralt E; Asselain B; Magdelenat H; Pouillart P
    Bull Cancer; 1984; 71(2):148. PubMed ID: 6733294
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer.
    Nemoto T; Patel JK; Rosner D; Dao TL; Halvorson H
    J Surg Oncol; 1989 Aug; 41(4):226-9. PubMed ID: 2526907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined tamoxifen and medroxyprogesterone treatment on coagulation-fibrinolytic systems in patients with advanced breast cancer.
    Fukutomi T; Adachi I; Watanabe T; Nanasawa T; Yamamoto H
    Acta Oncol; 1993; 32(5):573-4. PubMed ID: 8217244
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer].
    Mitsuyama S; Kuroda Y; Ohsato K; Nakamura Y; Murakami F; Nishikata F; Ikeda S; Egami T; Mori A; Ohe H
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1153-60. PubMed ID: 8751803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethinyl estradiol and medroxyprogesterone treatment in advanced breast cancer: a pilot study.
    Pellegrini A; Massidda B; Mascia V; Ionta MT; Lippi MG; Muggiano A; Carboni E; Robustelli della Cuna G; Bernardo G; Strada MR; Pavesi L
    Cancer Treat Rep; 1981; 65(1-2):135-6. PubMed ID: 7226163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):447-54. PubMed ID: 8678496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overall evaluation of the results of treatment of metastatic carcinomas of the breast with high doses of MAP combined with bromocryptin].
    Mussa A; Dogliotti L; Di Carlo F
    Minerva Med; 1980 Feb; 71(6):391-400. PubMed ID: 7360379
    [No Abstract]   [Full Text] [Related]  

  • 15. [A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer].
    Sommer H; Pröhl-Steimer B; Bajetta E; Haus U; Janni W; Kay A
    Zentralbl Gynakol; 2001 Oct; 123(10):557-61. PubMed ID: 11753809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
    Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
    J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
    [No Abstract]   [Full Text] [Related]  

  • 17. [High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma].
    Bastert G; Michel RT
    Med Welt; 1983 Mar; 34(12):378-82. PubMed ID: 6222235
    [No Abstract]   [Full Text] [Related]  

  • 18. [High-dosed gestagen therapy of the metastatic mammary carcinoma (author's transl)].
    Firusian N; Becher R
    Strahlentherapie; 1981 Dec; 157(12):808-12. PubMed ID: 7330909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
    Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
    Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tamoxifen in treating disseminated breast cancer].
    Dement'eva NP; Ass NIa; Koroleva LA; Lipovich MM; Stsetsevich NV
    Vopr Onkol; 1981; 27(8):30-4. PubMed ID: 7281591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.